In present study, we attempted to classify primary CNS DLBCLs into two biologically relevant subgroups based on the mutational status of CD79B and PIM1 by targeted exome sequencing covering 413 genes. This evidence concerns the gene PIM1 and diffuse large B-cell lymphoma of the central nervous system.